STRA is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading near support and is not collapsing, but the trend is still mixed to weak, analyst sentiment has been deteriorating, and recent fundamentals appear soft. For an impatient buyer, this is not a strong enough setup to buy aggressively today.
Current price is 79.06, slightly above the pivot at 78.675 and below resistance at 80.421. Momentum is neutral: RSI_6 is 48.9, showing no clear directional edge. MACD histogram is positive at 0.162 but contracting, which suggests weakening upside momentum. The moving average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend remains weak despite the short-term stabilization. Overall, the chart looks range-bound to mildly bearish, with 78.68 as immediate support and 80.42 as immediate resistance.

["Southern New Hampshire University partnered with Workforce Edge to expand access to 200+ online educational programs, which supports the education platform and employer channel.", "BMO noted growth rates could improve later in the year, even if partly due to easier comparisons.", "Truist saw U.S. Higher Education enrollment potentially returning to year-over-year growth by the end of 2026."]
["Q1 results missed consensus, with softer-than-expected U.S. Higher Education revenue and margins.", "Truist lowered its price target to $80 and kept a Hold rating after the Q1 miss.", "Barrington cut its target to $95 from $105 after results came in below expectations.", "Analysts said demand remains subdued and international enrollments in Australia and New Zealand continue to pressure outlooks.", "The stock has a bearish moving average structure, showing the broader trend is still weak."]
No detailed financial snapshot was available, but the latest quarter discussed by analysts was Q1. The quarter appears mixed-to-weak: revenue and EPS missed expectations, and U.S. Higher Education segment revenues and margins were softer than expected. There were some offsetting positives, such as enrollment beating one estimate and cost controls/AI-driven efficiencies helping EBITDA in the prior quarter, but the latest quarter overall does not show strong growth momentum.
Analyst sentiment has weakened recently. BMO kept Outperform but cut the target to $86 from $95 after the Q1 miss. Truist downgraded the stock to Hold from Buy and reduced its target to $80 from $85, citing a harder path to revenue growth. Barrington also cut its target to $95 from $105 while staying Outperform. Overall, Wall Street is split but leaning cautious: some pros still like the long-term story, but recent cuts and the Hold downgrade show concern about near-term execution and demand.